Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | RAC2 | P15153 | 1/20 | 0.33 |
| ▸ | RAC3 | P60763 | 1/20 | 0.33 |
| ▸ | CDC42 | P60953 | 1/20 | 0.33 |
| ▸ | RAC1 | P63000 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24988401 | 1.00 | KDM4E (0.47) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL24987507 | 1.00 | KDM4E (0.47) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL24987630 | 1.00 | KDM4E (0.47) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL24064785 | 0.96 | KDM4E (0.46) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL24985936 | 0.96 | KDM4E (0.52) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL23622745 | 0.96 | KDM4E (0.52) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL25449254 | 0.96 | KDM4E (0.52) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL23622564 | 0.96 | KDM4E (0.52) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL24089291 | 0.96 | KDM4E (0.52) | KDM4EATML3MBTL1RAC2RAC3 | |
| SCHEMBL24987484 | 0.96 | KDM4E (0.52) | KDM4EATML3MBTL1PTPN1MAT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019868-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230019868-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, AOX1, ODC1 | KDM4E 3300/4885ATM 3528/4885L3MBTL1 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.